L Prakash¹*, Arvind Diwaker Jain², Shabir Dhar³ and Sajid Jamal⁴

¹Consultant Orthopaedic Surgeon, Palakkad, Kerala, India
²Consultant Orthopaedic Surgeon, Lalitpur, Uttar Pradesh, India
³Consultant Orthopaedic Surgeon, Srinagar, India
⁴Consultant Orthopaedic Surgeon, Calicut, Kerala, India

*Corresponding Author: L Prakash, Consultant Orthopaedic Surgeon, Palakkad, Kerala, India.

Received: May 11, 2021; Published: May 20, 2021

Abstract

Pulmonary compromise and rapidly diminishing serum oxygen levels (SpO₂), affects a significant number of patients suffering from Covid 19, and often necessities hospitalisation and administration of oxygen! Cytokine storm has been identified as one of the principal causes of this diminution of oxygen concentrations. Anti-inflammatory agents are known to assist in control of cytokine storms, and the current study is an observation of 2003 Covid 19 patients, who were administered 20 mg sublingual cuboidal crystals of Piroxicam daily for five days. 134 participating clinicians shared their experience with the molecule. It was observed that Piroxicam was capable of controlling cytokine storm, and rapidly improving oxygen saturation in over 90% of patients and the effect of a single tablet was sustained for over 24 hours.

Keywords: Sublingual Piroxicam; Hypoxia; Cytokine Storm; Covid 19 Pneumonia

References

1. Singh TU., et al. “Drug repurposing approach to fight COVID-19”. Pharmacological Reports 6 (2020): 1479-1508.
2. Jennifer S Chen., et al. “Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection”. Journal of Virology 7 (2021).
3. DO Sordelli., et al. “Piroxicam treatment protects mice from lethal pulmonary challenge with Pseudomonas aeruginosa”. Journal of Infectious Disease 2 (1989): 232-238.
4. Mostafa A., et al. “FDA- Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2”. Pharmaceuticals12 (2020): 443.
5. https://m.facebook.com/groups/medicalalliance/permalink/10158272423866302/
6. Sun X., et al. “Cytokine storm intervention in the early stages of COVID-19 pneumonia”. Cytokine and Growth Factor Reviews 53 (2020): 38-42.
7. Akilesh SM., et al. “Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight”. Current Pharmaceutical Biotechnology 2 (2021): 192-199.